An official invitation letter will be provided upon successful registration for your participation in the conference.
학술대회 참가 등록이 정상적으로 완료되면 공식 초청장이 발급됩니다.
Plenary, keynote and parallel sessions.
전체회의, 기조연설 및 분과 세션.
Connect with fellow researchers.
동료 연구자들과의 교류.
Digital certificate of participation.
디지털 참가 증명서 발급.
Official letter after successful registration.
등록 완료 후 공식 초청장 발급.
E-proceedings & resource materials.
전자 논문집 및 참고 자료.
Learn from leading experts & scholars.
저명한 전문가 및 학자들의 강연.
The conference's session tracks effectively support the following SDGs.
본 학술대회의 세션 트랙은 다음의 지속가능발전목표를 효과적으로 지원합니다.
This track focuses on the latest advancements in pharmacotherapy for critically ill patients. It aims to explore novel drug formulations and therapeutic strategies that enhance patient outcomes in intensive care settings.
This session will delve into the application of translational medicine principles in critical care pharmacology. Participants will discuss the integration of laboratory research findings into clinical practice to improve therapeutic interventions.
This track addresses the critical importance of drug safety monitoring in intensive care units. It will cover methodologies for assessing adverse drug reactions and strategies for enhancing patient safety during pharmacotherapy.
This session will examine the pharmacological approaches to managing various critical illnesses. Experts will present evidence-based practices and emerging therapies that optimize treatment in acute care settings.
This track highlights the essential role of critical care nurses in pharmacological management. Discussions will focus on collaborative practices that enhance medication administration and patient monitoring in intensive care.
This session will explore cutting-edge research and innovations in drug development specifically tailored for critical care applications. Attendees will learn about the challenges and opportunities in bringing new therapies to the bedside.
This track will focus on the principles of clinical pharmacology as they apply to critically ill patients. Topics will include pharmacokinetics, pharmacodynamics, and individualized therapy approaches in intensive care.
This session will address the ethical dilemmas faced in pharmacological interventions within critical care. Discussions will include informed consent, end-of-life care, and the balance between risk and benefit in drug therapy.
This track will highlight novel therapeutic agents and their potential roles in the management of critically ill patients. Participants will discuss the implications of these emerging therapies on clinical practice and patient outcomes.
This session will emphasize the importance of interdisciplinary collaboration in optimizing pharmacological care for critically ill patients. Experts from various fields will share insights on teamwork and communication strategies in intensive care.
This track will explore future research priorities and directions in the field of critical care pharmacology. Participants will engage in discussions about innovative research methodologies and potential areas for investigation to enhance patient care.